Assessment of intact fibroblast growth factor 23 in patients with heart failure with reduced ejection fraction

被引：0
|
作者：
Gruson, D. Damien [1 ]
Ahn, S. [1 ]
Ferracin, B. [1 ]
Rousseau, M. [1 ]
机构：
[1] St Luc Univ Clin, Brussels, Belgium
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2017年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P1170
引用
收藏
页码：290 / 290
页数：1
相关论文
共 50 条
  • [41] Longitudinal Changes in Ejection Fraction in Heart Failure Patients With Preserved and Reduced Ejection Fraction
    Dunlay, Shannon M.
    Roger, Veronique L.
    Weston, Susan A.
    Jiang, Ruoxiang
    Redfield, Margaret M.
    CIRCULATION-HEART FAILURE, 2012, 5 (06) : 720 - 726
  • [42] Heart failure with reduced ejection fraction
    Nature Reviews Disease Primers, 3 (1)
  • [43] Heart failure with reduced ejection fraction
    Bloom, Michelle W.
    Greenberg, Barry
    Jaarsma, Tiny
    Januzzi, James L.
    Lam, Carolyn S. P.
    Maggioni, Aldo P.
    Trochu, Jean-Noel
    Butler, Javed
    NATURE REVIEWS DISEASE PRIMERS, 2017, 3
  • [44] Heart failure with reduced ejection fraction
    Michelle W. Bloom
    Barry Greenberg
    Tiny Jaarsma
    James L. Januzzi
    Carolyn S. P. Lam
    Aldo P. Maggioni
    Jean-Noël Trochu
    Javed Butler
    Nature Reviews Disease Primers, 3
  • [45] Heart failure hospitalization in patients with reduced ejection fraction in a heart failure clinic
    Daniel Seabra, D.
    Oliveira, I.
    Neto, A.
    Andrade, A.
    Azevedo, J.
    Pinto, P.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 380 - 380
  • [46] Secondary valve regurgitation in patients with heart failure with preserved ejection fraction, heart failure with mid-range ejection fraction, and heart failure with reduced ejection fraction
    Bartko, Philipp E.
    Hulsmann, Martin
    Hung, Judy
    Pavo, Noemi
    Levine, Robert A.
    Pibarot, Philippe
    Vahanian, Alec
    Stone, Gregg W.
    Goliasch, Georg
    EUROPEAN HEART JOURNAL, 2020, 41 (29) : 2799 - +
  • [47] Acute Decompensated Heart Failure in Patients with Heart Failure with Reduced Ejection Fraction
    Fukata, Mitsuhiro
    HEART FAILURE CLINICS, 2020, 16 (02) : 187 - +
  • [48] Duration of heart failure and outcomes in patients with heart failure and reduced ejection fraction
    Tomer, M. Meenakshi
    Gannuscio, J.
    Valentova, M.
    Fonarow, G.
    Adamopoulos, C.
    Kanonidis, I.
    Deedwania, P.
    Aronow, W.
    Anker, S.
    Ahmed, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 196 - 197
  • [49] Growth differentiation factor 15 as mortality predictor in heart failure patients with non-reduced ejection fraction
    Mendez Fernandez, Ana Belen
    Ferrero-Gregori, Andreu
    Garcia-Osuna, Alvaro
    Mirabet-Perez, Sonia
    Jose Pirla-Buxo, Maria
    Cinca-Cuscullola, Juan
    Ordonez-Llanos, Jordi
    Roig Minguell, Eulalia
    ESC HEART FAILURE, 2020, 7 (05): : 2223 - 2229
  • [50] Usefulness of fibroblast growth factor 23 and soluble suppression of tumorigenicity 2 as predictors of poor outcome in heart failure with preserved ejection fraction
    Roy, C.
    Slimani, A.
    De Meester, C.
    Amzulescu, M.
    Ferracin, B.
    Ginion, A.
    Pasquet, A.
    Vancraeynest, D.
    Vanoverschelde, J. -L.
    Gerber, B.
    Beauloye, C.
    Horman, S.
    Gruson, D.
    Pouleur, A. -C.
    EUROPEAN HEART JOURNAL, 2018, 39 : 223 - 224
12345